1st to market advantage “Beta 3.0” Marijuana Breathalyzer“Beta 3.0” (Cannabix Marijuana Breathalyzer) device based on its FAIMS- (field asymmetric waveform ion mobility spectrometry) is 95% complete
Its always smarter to step into an investment early at 95% rather than 100%
BLO will have a monopoly on a market.
If this gem has dropped on your investment radar some how, your a lucky investor,
if you get into BLO at this stage.
Large Institutional investors have started making moves this afternoon.
Several large block orders.
CEO Rav Mlait states, “Cannabix Technologies continues to receive considerable interest from government and law enforcement for the development of its point of care Cannabix Marijuana Breathalyzer.
(this is world wide, not just North America)
TASER COMPARISON:
Taser International went public in May 2001, pricing its shares at $13.00
$135.00 per share in February 2004